Islam Khalid
SEC insider (Form 3/4/5 filer). CIK 0001701858. Director at Gain Therapeutics, Inc. (GANX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BETHESDA, MD.
Companies Islam Khalid has filed insider reports for
- Gain Therapeutics, Inc. (GANX): Director
- FENNEC PHARMACEUTICALS INC. (FENC): Director
Islam Khalid
CIK: 0001701858
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 15, 2026GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Jun 10, 2026FENC
FENNEC PHARMACEUTICALS INC.
AwardDirectStock Option
25K shares at avg. $8.70- - Jun 24, 2025GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15K shares- - Jun 3, 2025FENC
FENNEC PHARMACEUTICALS INC.
AwardDirectStock Option
25K shares at avg. $7.88-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jun 10, 2026 |  FENC FENNEC PHARMACEUTICALS INC. | Award Stock Option | 25,000 | $8.70 | - | Direct |
| Jun 24, 2025 | GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 15,000 | - | - | Direct |
| Jun 3, 2025 | FENC FENNEC PHARMACEUTICALS INC. | Award Stock Option | 25,000 | $7.88 | - | Direct |
1-4 of 4 transactions